SA
ABBV icon

Sanctuary Advisors’s AbbVie ABBV Stock Holding History

Sanctuary Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104M Buy
479,197
+128
+0% +$28.4K 0.56% 28
2025
Q4 		$109M Buy
479,069
+6,911
+1% +$1.57M 0.6% 28
2025
Q3 		$109M Sell
472,158
-8,271
-2% -$1.68M 0.63% 27
2025
Q2 		$89.2M Sell
480,429
-3,937
-0.8% -$732K 0.55% 29
2025
Q1 		$101M Sell
484,366
-3,471
-0.7% -$675K 0.71% 22
2024
Q4 		$85.7M Sell
487,837
-40,965
-8% -$7.53M 0.54% 30
2024
Q3 		$93.6M Buy
528,802
+101,455
+24% +$18.9M 0.59% 26
2024
Q2 		$68.2M Buy
+427,347
New +$70.8M 0.5% 32

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanctuary Advisors's ABBV Position: Q1 2026 in Review

Sanctuary Advisors increased its AbbVie (ABBV) stake by 0.03% in Q1 2026, buying an estimated $28.4K and bringing the position to 479,197 shares worth $104M. The position accounts for 0.56% of the portfolio, ranked #28.

Sanctuary Advisors first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $109M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Sanctuary Advisors held 479,197 shares of AbbVie worth $104M as of Q1 2026.
  • Sanctuary Advisors bought 128 AbbVie shares in Q1 2026, an estimated $28.4K.
  • AbbVie made up 0.56% of Sanctuary Advisors's portfolio in Q1 2026, its #28 holding.
  • Sanctuary Advisors first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
  • Sanctuary Advisors's AbbVie position peaked at $109M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.